The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy.
缺氧选择性细胞毒素 NLCQ-1 (NSC 709257) 在用作放射疗法的辅助药物时，可控制转移性疾病
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/sj.bjc.6605753
Lunt S J, Cawthorne C, Ali M, Telfer B A, Babur M, Smigova A, Julyan P J, Price P M, Stratford I J, Bloomer W D, Papadopoulou M V, Williams K J
